In this randomized, controlled, crossover trial, nine non-diabetic insulin-resistant volunteers with obesity, aged 49 ± 7 years, were subjected to two periods of supplementation (placebo and PPEP) for 3 months. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.